Početna › Intersticijske bolesti pluća › Kalifornija
Kliničke studije za Intersticijske bolesti pluća u državi Kalifornija
22 studija za Intersticijske bolesti pluća traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Službeni tekst studije (engleski)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Southern California, Los Angeles
- Newport Native MD, Inc, Newport Beach
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of California Los Angeles, Los Angeles
U tijeku regrutacijaFaza 3
Od 40 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA007, Fresno
- USA010, Los Angeles
- USA023, Los Angeles
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07179380A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Los Angeles
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Orange
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06572384Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- San Francisco, San Francisco
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- i još 1
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Paradigm Clinical Research Centers, LLC, San Diego
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- HCA Riverside Community Hospital, Riverside
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- David Geffen School of Medicine at UCLA, Los Angeles
- University of California, San Francisco, San Francisco
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Santa Barbara
- Clinical Research Site, Torrance
U tijeku regrutacijaFaza 2
Od 18 do 85 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Cedars-Sinai Medical Center, Los Angeles
- UC Davis Health Medical Center, Sacramento
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University Medical Center, Palo Alto
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT06195072Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
U tijeku regrutacijaOpažajna studija
Od 21 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- University of California, San Francisco, San Francisco
U tijeku regrutacijaFaza 2
Od 4 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Peter Morton Medical Building, Los Angeles
- NewportNativeMD, Inc., Newport Beach
- University of California Irvine Medical Center, Orange
- i još 4
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- The Medical Research Group, Inc., Fresno
U tijeku regrutacijaOpažajna studija
Od 18 do 80 godina · Oba spola · Ažurirano 26. lip 2026. · NCT06129240TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- University of California San Francisco, San Francisco
U tijeku regrutacijaOpažajna studija
Do 24 godina · Oba spola · Ažurirano 22. lip 2026. · NCT04098445Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 12. stu 2025. · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Los Angeles
- aTyr Investigative Site, San Diego
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 7. svi 2025. · NCT05892614Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of California San Francisco, San Francisco
U tijeku regrutacijaOpažajna studija
Od 18 do 90 godina · Oba spola · Ažurirano 3. svi 2024. · NCT06397677Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.